FITC anti-mouse IFN-γ Antibody

Pricing & Availability
Clone
XMG1.2 (See other available formats)
Regulatory Status
RUO
Other Names
Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF)
Isotype
Rat IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
505805 25 µg £23
Check Availability


Need larger quantities of this item?
Request Bulk Quote
505806 100 µg £68
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IFN-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
E. coli-expressed, recombinant mouse IFN-γ
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The IFN-γ antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

ELISA1-4,11,14 or ELISPOT5 Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-? (Cat. No. 575309) as the standard.
ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-? (Cat. No. 575309) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture (Cat. No. 505812).
Flow Cytometry7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-?-producing cells within mixed cell populations.
Neutralization1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-?. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IFN-? bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of frozen tissue sections6,22,23, and immunocytochemistry.
Note: For testing mouse IFN-? in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 430801 to 430806) are specially developed and recommended.

Application References

(PubMed link indicates BioLegend citation)
  1. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut)
  2. Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut)
  3. Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut)
  4. Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA)
  5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT)
  6. Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC)
  7. Ferrick D, et al. 1995. Nature 373:255. (FC)
  8. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  9. Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut)
  10. DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut)
  11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
  12. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  13. Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed
  14. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
  15. Montfort M, et al.2004. J. Immunol. 173:4084. PubMed
  16. Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed
  17. Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed
  18. Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed
  19. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  20. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
  21. Mykkanen OT, et al. 2014. PLoS One. 9:114790. PubMed
  22. Yokogawa M, et al. 2013. Mol. Carcinog. 52:760. (IHC)
  23. Mottram PL, et al. 1998. J Immunol. 161:602. (IHC)
Product Citations
  1. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  2. Gao X, et al. 2010. Mol Immunol. 47:2397. PubMed
  3. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  4. Brenndörfer E, et al. 2014. J Immunol. 192:1671. PubMed
  5. Kedzierski L, et al. 2014. PLoS Pathog. 10:1004134. PubMed
  6. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  7. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  8. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  9. Wei F, et al. 2014. Cancer Res. 74:5989. PubMed
  10. Ni P, et al. 2014. Mol Immunol. 62:199. PubMed
  11. White C, et al. 2015. J Immunol. 194:697. PubMed
  12. Weigelin B, et al. 2015. Proc Natl Acad Sci U S A. 112:7551. PubMed
  13. Li Y, et al. 2015. J Nutr Biochem. Available online 8 August 2015. PubMed
  14. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  15. Lebrun A, et al. 2015. J Immunol. 195: 4358 - 4368. PubMed
  16. Pinget G, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.48. PubMed
  17. Sood S, et al. 2016. J Immunol. 197: 429 - 440. PubMed
  18. Zamora-Chimal J, et al. 2017. Immunobiology. 222(2):454-462. PubMed
  19. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  20. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  21. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  22. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  23. Vardhana SA, et al. 2020. Nat Immunol. 1.584722222. PubMed
  24. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  25. Kim EH, et al. 2020. Elife. 9:00. PubMed
  26. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  27. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  28. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  29. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  30. Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed
  31. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  32. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  33. Dai X, et al. 2021. Molecular Cell. 81(11):2317-2331.e6. PubMed
  34. Onodera A, et al. 2017. J Immunol. 10.4049/jimmunol.1602129. PubMed
  35. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  36. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  37. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  38. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  39. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  40. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  41. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  42. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  43. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  44. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  45. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  46. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  47. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  48. Nika L, et al. 2019. Vaccines (Basel). 7. PubMed
  49. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  50. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  51. Alessandrini F, et al. 2019. Oncogene. 38:4467. PubMed
  52. Gagnon JD, et al. 2019. Cell Rep. 28:2169. PubMed
  53. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  54. Sophie Thiemann et al. 2017. Cell host & microbe. 21(6):682-694 . PubMed
  55. Guo C, et al. 2017. Methods Mol Biol. 1709:345. PubMed
  56. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  57. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  58. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  59. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  60. Magen A, et al. 2019. Cell Rep. 29:3019. PubMed
  61. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
  62. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  63. Nakornpakdee Y, et al. 2018. Asian Pac J Allergy Immunol. 36:265. PubMed
  64. Zeng J, et al. 2020. Int J Biol Sci. 1.939583333. PubMed
  65. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  66. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  67. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  68. Angelou CC, et al. 2020. Frontiers in Immunology. 2.586805556. PubMed
  69. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  70. Chao CC, et al. 2020. Cell. 179(7):1483-1498.e22.. PubMed
  71. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  72. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  73. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  74. Larena M, et al. 2011. J Virol. 85:5446. PubMed
RRID
AB_315399 (BioLegend Cat. No. 505805)
AB_315400 (BioLegend Cat. No. 505806)

Antigen Details

Structure
Cytokine; dimer; 40-80 kD (Mammalian)
Bioactivity
Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APCs
Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Targets
T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors
IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Cell Type
Tregs
Biology Area
Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151.

Regulation
Upregulated by IL-2, FGF-basic, EGF; downregulated by 1-α-25-Dihydroxy vitamin D3, dexamethasone
Gene ID
15978 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse IFN-γ

  • Biotin anti-mouse IFN-γ

  • FITC anti-mouse IFN-γ

  • PE anti-mouse IFN-γ

  • Purified anti-mouse IFN-γ

  • Alexa Fluor® 488 anti-mouse IFN-γ

  • Alexa Fluor® 647 anti-mouse IFN-γ

  • Pacific Blue™ anti-mouse IFN-γ

  • PerCP/Cyanine5.5 anti-mouse IFN-γ

  • PE/Cyanine7 anti-mouse IFN-γ

  • Brilliant Violet 421™ anti-mouse IFN-γ

  • Brilliant Violet 650™ anti-mouse IFN-γ

  • Ultra-LEAF™ Purified anti-mouse IFN-γ

  • Brilliant Violet 711™ anti-mouse IFN-γ

  • Brilliant Violet 785™ anti-mouse IFN-γ

  • Brilliant Violet 605™ anti-mouse IFN-γ

  • Brilliant Violet 510™ anti-mouse IFN-γ

  • Purified anti-mouse IFN-γ (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse IFN-γ

  • Alexa Fluor® 700 anti-mouse IFN-γ

  • APC/Cyanine7 anti-mouse IFN-γ

  • GoInVivo™ Purified anti-mouse IFN-γ

  • APC/Fire™ 750 anti-mouse IFN-γ

  • Spark NIR™ 685 anti-mouse IFN-γ

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account